This elevation of calreticulin levels on cancer cell surface appears to enhance its potential of promoting ICD, presumably by boosting their removal by antigen-presenting cells through phagocytosis pathways optimized for recognition of tumor antigens. The gene discussed is CALR; the disease is cancer.